Renewing Mycapssa (Octreotide Oral) Approval with UnitedHealthcare in North Carolina: Complete 2025 Guide
Answer Box: Mycapssa Renewal Essentials
UnitedHealthcare requires annual reauthorization for Mycapssa (oral octreotide) in North Carolina, approving 12-month renewals based on documented clinical response—typically normalized IGF-1 levels and symptom improvement. Submit renewal requests 30-60 days before expiration via the OptumRx Provider Portal or fax (866-889-8054) with recent labs, treatment